Clinical Data

Cartoon of businessmen standing around a broken target
Biotech

Arcus halts Gilead-partnered TIGIT trials as it reworks R&D

A key late-stage trial of Arcus Biosciences and Gilead’s anti-TIGIT antibody domvanalimab has flopped.
Ben Adams Dec 12, 2025 10:00am
stock image of a glucose meter with a blood strip

Rezolute stock sinks 87% as hypoglycemia drug fails ph. 3 test

Dec 11, 2025 9:45am
obesity overweight weight loss weigh

Lilly's obesity triple threat tops phase 3 efficacy forecasts

Dec 11, 2025 8:15am
Lung

GRI touts IPF safety edge, lung function gains amid cash crunch

Dec 11, 2025 5:12am
An arrow incrementally going up stairs before pointing straight up Blue background

Roche links SERD to 30% breast cancer risk reduction in phase 3

Dec 10, 2025 8:15am
Basketball players hands reaching for a ball near the hoop during a professional game

Exicure scores in phase 2 multiple myeloma program

Dec 9, 2025 10:15am